AKAikorkem Kyzkenova

Aikorkem Kyzkenova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aikorkem Kyzkenova has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis and Antiviral Activity of 1-(4-Pyridin-2-yl-[1,2,3]triazol-1-ylmethyl)-octahydro-quinolizine

    by Zhangeldy Nurmaganbetov, Roza Seidakhmetova, Khorlan Itzhanova, Pernesh Bekisheva, Aikorkem Kyzkenova

    The antiviral activity of compound (5) was demonstrated by a reduction in influenza A viral infectivity of 2.0 log10 for H3N2 (99% inactivation) and 1.9 log10 for H1N1 (98.7% inactivation) at a dose of 0.4 mg/embryo. The compound demonstrated no noticeable embryotoxicity at the maximum tested dose of 0.4 mg/embryo, while the LD50 was not reached within the investigated concentration range. Notably, its therapeutic index outperforms rimantadine and oseltamivir. Furthermore, a scalable 8-stage laboratory production protocol was successfully validated. These findings position compound (5) as a highly promising, low-toxicity domestic prototype for the development of innovative, multi-targeted anti-influenza pharmaceutical drugs.